Home

Not a member? Sign up!

Forgot your password?

Canopus Biopharma and leading chinese researcher, Dr. Jiahai Lu, team up to treat avian influenza with StatC...

Added: August 12, 2008 | Time 10:36 | Views: 150

Canopus Biopharma and leading chinese researcher, Dr. Jiahai Lu, team up to treat avian influenza with StatC, to prevent possible pandemic.

An internationally renowned avian influenza expert today hailed "encouraging and exciting" results from experiments conducted by his research team. This study demonstrated impressive efficacy of a novel statin/caffeine combination, StatC™ in the treatment and prevention of H5N1, H1N1 and H3N2 in a mouse model.

Dr. Jiahai Lu, from the School of Public Health, Sun Yat-sen University in Guangzhou, China, has published extensively in the field of avian influenza, and has been researching the breakthrough compound StatC™ for the past two years on behalf of Canopus BioPharma (OTCPK:CBIA), a US corporation who discovered and patented the potential of this antiviral candidate.

To view Multimedia News Release go to, http://www.prnewswire.com/mnr/canopusbiopharma/34441/

Topics: Influenza

Tags: AVIAN, BIOPHARMA, CANOPUS, drugs, H1N1, H3N2, H5N1, influenza, Jiahai, Lu, Multivu 34441, oseltamivir, Relenza, StatC, Tamiflu, testing, zanamivir

Embed:

Comments

Post a Comment

Please log in at the top of the page to post a comment!

Navigation

Popular Health Topics

Community

Company Information

Site Links

Resources / Support

By using this service, you accept our Terms of Service. Please read them. The health information on this site is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen.